Topic Review
Strategies for the Appropriateness of Medication Use
The evidence on the effectiveness of strategies and tools to promote and improve medication appropriateness and their sustainability largely derives from local and heterogeneous experiences with contrasting results. As a general framework, three main steps should be considered in implementing measures to improve the appropriateness of medications: prescription, acceptance by the patient, and continuous monitoring of adherence and the risk-benefit profile. Each step needs efforts from specific actors (physicians, patients, caregivers, healthcare professionals) and dedicated supporting tools. Moreover, how to support the appropriateness also strictly depends on the particular care setting (hospital, ambulatory or primary care, nursing home, long-term care) and available economic resources. 
  • 330
  • 23 Sep 2022
Topic Review
Solid Lipid Nanoparticle Preparation Techniques
Solid lipid nanoparticles (SLNs) are an alternate carrier system to liposomes, polymeric nanoparticles, and inorganic carriers. SLNs have attracted increasing attention for delivering drugs, nucleic acids, proteins, peptides, nutraceuticals, and cosmetics. These nanocarriers have attracted industrial attention due to their ease of preparation, physicochemical stability, and scalability. These characteristics make SLNs attractive for manufacture on a large scale. 
  • 944
  • 23 Sep 2022
Topic Review
The Antimicrobial Resistance
The resistance of microorganisms has appeared since the first antimicrobial was used. Antimicrobial resistance is the ability of microorganisms (such as bacteria, viruses, fungi, or parasites) to resist the action of an antimicrobial agent.
  • 433
  • 22 Sep 2022
Topic Review
Antibiotic Hybrids
An emerging strategy in the fight against antimicrobial resistance is the development of antibiotic hybrids. The term “hybrid” suggests a two-component molecule with biological activity that retains the activity of the individual components after hybridization, acting synergistically. For example, hybrid drugs that incorporate two active compounds into a single molecule could be used to expand the biological activity and prevent the development of bacterial resistance.
  • 914
  • 22 Sep 2022
Topic Review
Aqueous Soluble Drug
The low water solubility of pharmacoactive molecules limits their pharmacological potential, but the solubility parameter cannot compromise, and so different approaches are employed to enhance their bioavailability. Pharmaceutically active molecules with low solubility convey a higher risk of failure for drug innovation and development. Pharmacokinetics, pharmacodynamics, and several other parameters, such as drug distribution, protein binding and absorption, are majorly affected by their solubility.
  • 1.3K
  • 20 Sep 2022
Topic Review
Electrospinning of Essential Oils
Essential oils (EOs) have been widely exploited for their biological properties (mainly as antimicrobials) in the food industry. Encapsulation of EOs has opened the way to the utilization of EOs in the pharmaceutical and biomedical fields. Electrospinning (ES) has proved a convenient and versatile method for the encapsulation of EOs into multifunctional nanofibers.
  • 461
  • 20 Sep 2022
Topic Review
Biopolymer Based Prodrugs as Potential Antineoplastic Therapy
Cancer represents a major public health issue, a substantial economic issue, and a burden for society. Limited by numerous disadvantages, conventional chemotherapy is being replaced by new strategies targeting tumor cells. In this context, therapies based on biopolymer prodrug systems represent a promising alternative for improving the pharmacokinetic and pharmacologic properties of drugs and reducing their toxicity. The polymer-directed enzyme prodrug therapy is based on tumor cell targeting and release of the drug using polymer–drug and polymer–enzyme conjugates. In addition, current trends are oriented towards natural sources. They are biocompatible, biodegradable, and represent a valuable and renewable source. Drug–polymer conjugates based on natural polymers such as chitosan (CTS), hyaluronic acid (HA), dextran (DEX), pullulan (PL), silk fibroin (SF), centyrins (CTR), heparin (HEP), and polysaccharides from Auricularia auricula (AAP) are presented. 
  • 563
  • 19 Sep 2022
Topic Review
Monoclonal Antibodies in Treating Inflammatory Bowel Disease
Monoclonal antibodies (MAbs) have revolutionized the treatment of many chronic inflammatory diseases, including inflammatory bowel disease (IBD). IBD is a term that comprises two quite similar, yet distinctive, disorders—Crohn’s disease (CD) and ulcerative colitis (UC). Two blockbuster MAbs, infliximab (IFX) and adalimumab (ADL), transformed the pharmacological approach of treating CD and UC. However, due to the complex interplay of pharmacology and immunology, MAbs face challenges related to their immunogenicity, effectiveness, and safety.
  • 391
  • 19 Sep 2022
Topic Review
The Mechanism-Based Inactivation of CYP3A4 by Ritonavir
Ritonavir is the most potent cytochrome P450 (CYP) 3A4 inhibitor in clinical use and is often applied as a booster for drugs with low oral bioavailability due to CYP3A4-mediated biotransformation, as in the treatment of HIV (e.g., lopinavir/ritonavir) and more recently COVID-19 (Paxlovid or nirmatrelvir/ritonavir). Ritonavir is clearly a potent mechanism-based inactivator, which irreversibly blocks CYP3A4. 
  • 833
  • 19 Sep 2022
Topic Review
Therapeutic Actions of Anthocyanins in Chronic Diseases
Anthocyanins are secondary metabolites and distributed in flowers, fruits and vegetables. They provide various colours such as red, pink, blue and purple. To date, more than 700 anthocyanins have been identified in nature. These anthocyanins have been associated with many health benefits through different mechanisms. Some of the therapeutic potentials of anthocyanins and their mechanisms of action are highlighted.
  • 910
  • 18 Sep 2022
  • Page
  • of
  • 106
Video Production Service